- Served as antitrust counsel to one of the largest American retail pharmacies. Our team represented the corporation in its transactions, litigation, and other matters before both state and federal antitrust authorities.
- Represented one of the nation’s leading hospital and physicians networks in connection with its acquisitions of three community hospitals and a large physician group.
- Represented a market leading producer and distributor of environmentally-safe household products in its acquisition by another transnational consumer goods company.
- Represented a leading provider of sample and assay technologies in the antitrust aspects of its $1.5 billion acquisition of another life sciences company.
- Served as antitrust counsel for a hospital in its merger with another medical center.
- Served as antitrust counsel for a leading provider of sample and assay technologies, and are currently involved in counseling and representing the company in merger and acquisition activities.
Mintz is leading a NYSE company’s defense in US criminal price-fixing cartel investigations and a US class action with nearly two dozen codefendants. Mintz is also coordinating with non-US counsel on related foreign actions regarding the alleged international cartel.
Mintz has been lead transaction counsel for a large radiology group practice since its April 2013 inception, including for major acquisitions in Texas, Arizona, California, and Louisiana. Mintz has also led debt and equity refinancings for the client totaling more than $1 billion in capital.
Mintz guided a Fortune 50 corporation through a joint investigation by the Federal Trade Commission’s Bureau of Competition and Bureau of Consumer Protection that included civil investigative demands and hearings. The corporation’s merger was preserved, and none of its actions was challenged.
Mintz led a heavily negotiated settlement that enabled a large health care system to acquire a hospital and physician group. The joint Department of Justice, state Attorney General, and state agency investigation included a “second request” in accordance with the Hart-Scott-Rodino (HSR) Act.